Parenteral Systemic Anti-Cancer Therapies and Other Biologicals Including Immunotherapies
Estimated value
£32.0m
Awarded value
—
Suppliers
1
Lots
1
Published
05 Apr 2019
Description
Delivery of an Parenteral Systemic Anti-Cancer Therapies and Other Biologicals Inc. Immunotherapies Homecare service from a GPhC registered Pharmacy. This will involve dispensing and delivering a range of medicines, with the option required to deliver Ancillaries, remove waste product, provide suitable fridge, nursing administration of medicines. Membership of the EMPC may vary throughout the life of the contract. Access to this contract may vary upon membership. Other UK and/or other participating NHS bodies (whether acting individually, or on behalf of, or together as members of any consortia) may become EMPC members during the life of any resulting contract. This tender is to establish a framework agreement for the supply of an Parenteral Systemic Anti-Cancer Therapies and Other Biologicals Inc. Immunotherapies Homecare service to participating trusts, in line with the agreed specification. East Midlands Pharmacy Collaboration (EMPC) is a procurement collaborative hosted by Royal Derby Hospitals, NHS Foundation Trust, acting as an agent on behalf of its Member Organisations. The member organisations working with EMPC and who may purchase under any contract awarded through this process can be found at http://www.derbyhospitals.nhs.uk/primary/pharmacy/empc/ .
Scope
- Reference
- D85.D22
- Total value
- £32,000,000 excluding VAT
- Commercial tool
- Standalone contract
- Contract dates
- 01 Feb 2019 to 31 Jan 2023
- CPV classifications
- 33000000 85140000
- Particular suitability
- Small and medium-sized enterprises (SME)
Submission & procedure
- Submission deadline
- 18 Oct 2018, 11:00 pm
Award details
Awarded supplier(s), contract period and value as published in the award notice.
Awarded value
—
Award date
15 Mar 2019
Contract start
01 Feb 2019
Contract end
31 Jan 2023